Derivation of An In-Hospital Cardiac Arrest Prediction Model for Patients in Intensive Care Unit

NCT ID: NCT04670458

Last Updated: 2020-12-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-10-01

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Current studies have shown that hospitalized ICU patients have a high risk of IHCA, with an incidence of about 0.6-7.8%. Early prediction of the occurrence of IHCA in severe patients can provide early intervention, prevent the deterioration of the disease, and reduce the incidence of IHCA. Therefore, researchers wanted to verify the efficacy of MEWS, NEWS, and CART scores in predicting IHCA in ICU inpatients, and to establish an early-warning scoring model that could effectively predict the risk of IHCA occurrence in ICU inpatients during hospitalization.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

In-Hospital Cardiac Arrest

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Critically ill patients In-Hospital Cardiac Arrest Early recognition Early warning score

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CA group

Patients with In-Hospital Cardiac Arrest

no intervention

Intervention Type OTHER

no intervention

CONTROL group

Patients without In-Hospital Cardiac Arrest

no intervention

Intervention Type OTHER

no intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

no intervention

no intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Occurrence of IHCA
* Hospital stay ≥48h.


* Without IHCA
* Hospital stay ≥48h

Exclusion Criteria

* \<14 years
* Do Not Resuscitat
* Patients hospitalized due to out-of-hospital cardiac arrest
* Cardiac arrest occurs during the operation
* The patients with implanted cardiac pacemaker suffered cardiac arrest due to instrument malfunction.

CONTROL group


* \<14 years
* Leave hospital without medical advice
Minimum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Qilu Hospital of Shandong University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Qilu Hospital of Shandong University

Jinan, Shandong, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wentao Sang

Role: CONTACT

Phone: 15153187102

Email: [email protected]

Feng Xu

Role: CONTACT

Phone: 18560083066

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Wentao Sang

Role: primary

Feng Xu

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IHCA-EWS-QLH

Identifier Type: -

Identifier Source: org_study_id